Familial cerebral amyloid angiopathy due to the iowa mutation in an Irish family

Canadian Journal of Neurological Sciences

Volumn 41, Issue 4, 2014, Pages 512-517

  Mok, Tzehow ^a   Chalissery, Albi J ^a   Byrne, Susan ^a   Costelloe, Lisa ^a   Galvin, Leo ^a   Vinters, Harry V ^b   Farrell, Michael A ^a   Brett, Francesca M ^a   Moroney, Joan T ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FAMILIAL DISEASE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IRELAND; PEDIGREE; PRIORITY JOURNAL; VASCULAR AMYLOIDOSIS; CAUCASIAN; CEREBRAL AMYLOID ANGIOPATHY, FAMILIAL; GENETICS; MIDDLE AGED; MUTATION;

CEREBRAL AMYLOID ANGIOPATHY, FAMILIAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; IRELAND; MIDDLE AGED; MUTATION; PEDIGREE;

EID: 84901763535     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S031716710001859X     Document Type: Article

References (31)

1. Yang ZJ, Liu J, Ge JP, Chen L, Zhao ZG, Yang WY. Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study. Eur Heart J. 2012;33(2):213-20.
2. Barrett-Connor E, Khaw KT. Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol. 1988;128(1):116-23.
3. Burchfiel CM, Curb JD, Rodriguez BL, Abbott RD, Chiu D, Yano K. Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program. Stroke. 1994;25(5):951-7. (Pubitemid 24130299)
4. Folsom AR, Rasmussen ML, Chambless LE, et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care. 1999; 22(7):1077-83. (Pubitemid 29293959)
5. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32(10): 2426-32. (Pubitemid 32954818)
6. Baird TA, Parsons MW, Phanh T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34(9): 2208-14. (Pubitemid 37099838)
7. Parsons MW, Barber PA, Desmond PM, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52(1):20-8. (Pubitemid 34693739)
8. Sykora M, Diedler J, Turcani P, Hacke W, Steiner T. Baroreflex: a new therapeutic target in human stroke? Stroke. 2009;40(12): e678-82.
9. Ay H, Arsava EM, Koroshetz WJ, Sorensen AG. Middle cerebral artery infarcts encompassing the insula are more prone to growth. Stroke. 2008;39(2):373-8. (Pubitemid 351619458)
10. Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial - revisited. Diabetes. 2008;57(4):995-1001.
11. Meigs JB, Nathan DM, D'Agostino RB, Sr., Wilson PW, Framingham Offspring Study. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care. 2002;25(10):1845-50. (Pubitemid 41071098)
12. Ceriello A, Hanefeld M, Leiter L, et al. Postprandial glucose regulation and diabetic complications. Arch Intern Med. 2004; 164(19):2090-5. (Pubitemid 39410797)
13. Gerich JE. Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch Intern Med. 2003;163(11): 1306-16. (Pubitemid 36676195)
14. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes. 2003;52(11):2795-804. (Pubitemid 37339710)
15. Brott T, Adams HP, Jr., Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20 (7):864-70. (Pubitemid 19188240)
16. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke. 1988;19(12):1497-500. (Pubitemid 19005804)
17. The Chinese Medical Association TCion. Diagnosis of cerebrovascular disease. J Neurology. 1996;29(6):379.
18. Colman PG, Thomas DW, Zimmet PZ, Welborn TA, Garcia-Webb P, Moore MP. New classification and criteria for diagnosis of diabetes mellitus. The Australasian Working Party on Diagnostic Criteria for Diabetes Mellitus. N Z Med J. 1999;112(1086): 139-41.
19. Gray CS, Hildreth AJ, Sandercock PA, et al. Glucose-potassiuminsulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GISTUK). Lancet Neurol. 2007;6(5):397-406. (Pubitemid 46551852)
20. Martini SR, Kent TA. Hyperglycemia in acute ischemic stroke: a vascular perspective. J Cereb Blood Flow Metab. 2007;27(3): 435-51.
21. Naber CK, Mehta RH, Junger C, et al. Impact of admission blood glucose on outcomes of nondiabetic patients with acute STelevation myocardial infarction (from the German Acute Coronary Syndromes [ACOS] Registry). Am J Cardiol. 2009; 103(5):583-7.
22. Williams LS, Rotich J, Qi R, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology. 2002;59(1):67-71. (Pubitemid 34742796)
23. D'Olhaberriague L, Litvan I, Mitsias P, Mansbach HH. A reappraisal of reliability and validity studies in stroke. Stroke. 1996;27(12):2331-6. (Pubitemid 26427215)
24. Suwa T, Ohta A, Matsui T, et al. Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM). Endocr J. 2010;57(2): 135-40.
25. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36(11): 3008-13.
26. Holmes MV, Newcombe P, Hubacek JA, et al. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet. 2011;378(9791): 584-94.
27. Phipps MS, Jastreboff AM, Furie K, Kernan WN. The diagnosis and management of cerebrovascular disease in diabetes. Curr Diab Rep. 2012;12(3):314-23.
28. Martin RJ, Ratan RR, Reding MJ, Olsen TS. Higher blood glucose within the normal range associated with more severe strokes. Stroke Res Treat. 2012;2012:659610.
29. Azuma K, Kawamori R, Toyofuku Y, et al. Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol. 2006;26 (10):2275-80. (Pubitemid 44465722)
30. Russo VC, Higgins S, Werther GA, Cameron FJ. Effects of fluctuating glucose levels on neuronal cells in vitro. Neurochem Res. 2012;37(8):1768-82.
31. Kim M, Chung H, Yoon C, et al. Increase of INS-1 cell apoptosis under glucose fluctuation and the involvement of FOXO-SIRT pathway. Diabetes Res Clin Pract. 2012;98(1):132-9.